APO RESEARCH · REPORT
Montelukast Sodium
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Product & engineering
Understand the product.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Selected research
Industry Growth & Trends
Global Montelukast Sodium Industry Growth and Trends Forecast to 2032
Market perspective
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Montelukast Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Montelukast Sodium market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Montelukast Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Montelukast Sodium.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Montelukast Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Montelukast Sodium Market by Company
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Montelukast Sodium Segment by Type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Montelukast Sodium Segment by Application
Tablets
Chewable Tablet
Oral Solution
Montelukast Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Montelukast Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Montelukast Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Montelukast Sodium Amorphous
- Montelukast Sodium Crystalline
Applications
- Tablets
- Chewable Tablet
- Oral Solution
Companies covered
- Morepen Laboratories
- Mylan
- TAPI
- MSN Laboratories
- Ultratech India
- Aurobindo Pharma
- Hetero Labs
- Unimark Remedies
- Jubilant Cadista
- Aamorb Pharmaceuticals
- Sudarshan Group
- Ortin Laboratories
- Vamsi Labs
- Adley Group
- Medopharm
- Hengyuan Pharmaceutical
- Arromax Pharmaceutical Technology
- Lihe Wuhan New Chemical Materials
- Shanghai Huachu Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Montelukast Sodium Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Montelukast Sodium Sales Estimates and Forecasts (2021-2032)
- 1.3 Montelukast Sodium Market by Type
- 1.3.1 Montelukast Sodium Amorphous
- 1.3.2 Montelukast Sodium Crystalline
- 1.4 Global Montelukast Sodium Market Size by Type
- 1.4.1 Global Montelukast Sodium Market Size Overview by Type (2021-2032)
- 1.4.2 Global Montelukast Sodium Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Montelukast Sodium Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Montelukast Sodium Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Montelukast Sodium Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Montelukast Sodium Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Montelukast Sodium Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Montelukast Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Montelukast Sodium Industry Trends
- 2.2 Montelukast Sodium Industry Drivers
- 2.3 Montelukast Sodium Industry Opportunities and Challenges
- 2.4 Montelukast Sodium Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Montelukast Sodium Revenue (2021-2026)
- 3.2 Global Top Players by Montelukast Sodium Sales (2021-2026)
- 3.3 Global Top Players by Montelukast Sodium Price (2021-2026)
- 3.4 Global Montelukast Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Montelukast Sodium Major Company Production Sites & Headquarters
- 3.6 Global Montelukast Sodium Company, Product Type & Application
- 3.7 Global Montelukast Sodium Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Montelukast Sodium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Montelukast Sodium Players Market Share by Revenue in 2025
- 3.8.3 2025 Montelukast Sodium Tier 1, Tier 2, and Tier 3
4 Montelukast Sodium Regional Status and Outlook
- 4.1 Global Montelukast Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Montelukast Sodium Historic Market Size by Region
- 4.2.1 Global Montelukast Sodium Sales in Volume by Region (2021-2026)
- 4.2.2 Global Montelukast Sodium Sales in Value by Region (2021-2026)
- 4.2.3 Global Montelukast Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Montelukast Sodium Forecasted Market Size by Region
- 4.3.1 Global Montelukast Sodium Sales in Volume by Region (2027-2032)
- 4.3.2 Global Montelukast Sodium Sales in Value by Region (2027-2032)
- 4.3.3 Global Montelukast Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Montelukast Sodium by Application
- 5.1 Montelukast Sodium Market by Application
- 5.1.1 Tablets
- 5.1.2 Chewable Tablet
- 5.1.3 Oral Solution
- 5.2 Global Montelukast Sodium Market Size by Application
- 5.2.1 Global Montelukast Sodium Market Size Overview by Application (2021-2032)
- 5.2.2 Global Montelukast Sodium Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Montelukast Sodium Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Montelukast Sodium Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Montelukast Sodium Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Montelukast Sodium Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Montelukast Sodium Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Montelukast Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Morepen Laboratories
- 6.1.1 Morepen Laboratories Company Information
- 6.1.2 Morepen Laboratories Business Overview
- 6.1.3 Morepen Laboratories Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Morepen Laboratories Montelukast Sodium Product Portfolio
- 6.1.5 Morepen Laboratories Recent Developments
- 6.2 Mylan
- 6.2.1 Mylan Company Information
- 6.2.2 Mylan Business Overview
- 6.2.3 Mylan Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Mylan Montelukast Sodium Product Portfolio
- 6.2.5 Mylan Recent Developments
- 6.3 TAPI
- 6.3.1 TAPI Company Information
- 6.3.2 TAPI Business Overview
- 6.3.3 TAPI Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 TAPI Montelukast Sodium Product Portfolio
- 6.3.5 TAPI Recent Developments
- 6.4 MSN Laboratories
- 6.4.1 MSN Laboratories Company Information
- 6.4.2 MSN Laboratories Business Overview
- 6.4.3 MSN Laboratories Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 MSN Laboratories Montelukast Sodium Product Portfolio
- 6.4.5 MSN Laboratories Recent Developments
- 6.5 Ultratech India
- 6.5.1 Ultratech India Company Information
- 6.5.2 Ultratech India Business Overview
- 6.5.3 Ultratech India Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ultratech India Montelukast Sodium Product Portfolio
- 6.5.5 Ultratech India Recent Developments
- 6.6 Aurobindo Pharma
- 6.6.1 Aurobindo Pharma Company Information
- 6.6.2 Aurobindo Pharma Business Overview
- 6.6.3 Aurobindo Pharma Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Aurobindo Pharma Montelukast Sodium Product Portfolio
- 6.6.5 Aurobindo Pharma Recent Developments
- 6.7 Hetero Labs
- 6.7.1 Hetero Labs Company Information
- 6.7.2 Hetero Labs Business Overview
- 6.7.3 Hetero Labs Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Hetero Labs Montelukast Sodium Product Portfolio
- 6.7.5 Hetero Labs Recent Developments
- 6.8 Unimark Remedies
- 6.8.1 Unimark Remedies Company Information
- 6.8.2 Unimark Remedies Business Overview
- 6.8.3 Unimark Remedies Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Unimark Remedies Montelukast Sodium Product Portfolio
- 6.8.5 Unimark Remedies Recent Developments
- 6.9 Jubilant Cadista
- 6.9.1 Jubilant Cadista Company Information
- 6.9.2 Jubilant Cadista Business Overview
- 6.9.3 Jubilant Cadista Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jubilant Cadista Montelukast Sodium Product Portfolio
- 6.9.5 Jubilant Cadista Recent Developments
- 6.10 Aamorb Pharmaceuticals
- 6.10.1 Aamorb Pharmaceuticals Company Information
- 6.10.2 Aamorb Pharmaceuticals Business Overview
- 6.10.3 Aamorb Pharmaceuticals Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Aamorb Pharmaceuticals Montelukast Sodium Product Portfolio
- 6.10.5 Aamorb Pharmaceuticals Recent Developments
- 6.11 Sudarshan Group
- 6.11.1 Sudarshan Group Company Information
- 6.11.2 Sudarshan Group Business Overview
- 6.11.3 Sudarshan Group Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sudarshan Group Montelukast Sodium Product Portfolio
- 6.11.5 Sudarshan Group Recent Developments
- 6.12 Ortin Laboratories
- 6.12.1 Ortin Laboratories Company Information
- 6.12.2 Ortin Laboratories Business Overview
- 6.12.3 Ortin Laboratories Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Ortin Laboratories Montelukast Sodium Product Portfolio
- 6.12.5 Ortin Laboratories Recent Developments
- 6.13 Vamsi Labs
- 6.13.1 Vamsi Labs Company Information
- 6.13.2 Vamsi Labs Business Overview
- 6.13.3 Vamsi Labs Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Vamsi Labs Montelukast Sodium Product Portfolio
- 6.13.5 Vamsi Labs Recent Developments
- 6.14 Adley Group
- 6.14.1 Adley Group Company Information
- 6.14.2 Adley Group Business Overview
- 6.14.3 Adley Group Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Adley Group Montelukast Sodium Product Portfolio
- 6.14.5 Adley Group Recent Developments
- 6.15 Medopharm
- 6.15.1 Medopharm Company Information
- 6.15.2 Medopharm Business Overview
- 6.15.3 Medopharm Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Medopharm Montelukast Sodium Product Portfolio
- 6.15.5 Medopharm Recent Developments
- 6.16 Hengyuan Pharmaceutical
- 6.16.1 Hengyuan Pharmaceutical Company Information
- 6.16.2 Hengyuan Pharmaceutical Business Overview
- 6.16.3 Hengyuan Pharmaceutical Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Hengyuan Pharmaceutical Montelukast Sodium Product Portfolio
- 6.16.5 Hengyuan Pharmaceutical Recent Developments
- 6.17 Arromax Pharmaceutical Technology
- 6.17.1 Arromax Pharmaceutical Technology Company Information
- 6.17.2 Arromax Pharmaceutical Technology Business Overview
- 6.17.3 Arromax Pharmaceutical Technology Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Arromax Pharmaceutical Technology Montelukast Sodium Product Portfolio
- 6.17.5 Arromax Pharmaceutical Technology Recent Developments
- 6.18 Lihe Wuhan New Chemical Materials
- 6.18.1 Lihe Wuhan New Chemical Materials Company Information
- 6.18.2 Lihe Wuhan New Chemical Materials Business Overview
- 6.18.3 Lihe Wuhan New Chemical Materials Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Lihe Wuhan New Chemical Materials Montelukast Sodium Product Portfolio
- 6.18.5 Lihe Wuhan New Chemical Materials Recent Developments
- 6.19 Shanghai Huachu Chemical
- 6.19.1 Shanghai Huachu Chemical Company Information
- 6.19.2 Shanghai Huachu Chemical Business Overview
- 6.19.3 Shanghai Huachu Chemical Montelukast Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Shanghai Huachu Chemical Montelukast Sodium Product Portfolio
- 6.19.5 Shanghai Huachu Chemical Recent Developments
7 North America by Country
- 7.1 North America Montelukast Sodium Sales by Country
- 7.1.1 North America Montelukast Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Montelukast Sodium Sales by Country (2021-2026)
- 7.1.3 North America Montelukast Sodium Sales Forecast by Country (2027-2032)
- 7.2 North America Montelukast Sodium Market Size by Country
- 7.2.1 North America Montelukast Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Montelukast Sodium Market Size by Country (2021-2026)
- 7.2.3 North America Montelukast Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Montelukast Sodium Sales by Country
- 8.1.1 Europe Montelukast Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Montelukast Sodium Sales by Country (2021-2026)
- 8.1.3 Europe Montelukast Sodium Sales Forecast by Country (2027-2032)
- 8.2 Europe Montelukast Sodium Market Size by Country
- 8.2.1 Europe Montelukast Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Montelukast Sodium Market Size by Country (2021-2026)
- 8.2.3 Europe Montelukast Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Montelukast Sodium Sales by Country
- 9.1.1 Asia-Pacific Montelukast Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Montelukast Sodium Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Montelukast Sodium Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Montelukast Sodium Market Size by Country
- 9.2.1 Asia-Pacific Montelukast Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Montelukast Sodium Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Montelukast Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Montelukast Sodium Sales by Country
- 10.1.1 South America Montelukast Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Montelukast Sodium Sales by Country (2021-2026)
- 10.1.3 South America Montelukast Sodium Sales Forecast by Country (2027-2032)
- 10.2 South America Montelukast Sodium Market Size by Country
- 10.2.1 South America Montelukast Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Montelukast Sodium Market Size by Country (2021-2026)
- 10.2.3 South America Montelukast Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Montelukast Sodium Sales by Country
- 11.1.1 Middle East and Africa Montelukast Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Montelukast Sodium Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Montelukast Sodium Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Montelukast Sodium Market Size by Country
- 11.2.1 Middle East and Africa Montelukast Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Montelukast Sodium Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Montelukast Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Montelukast Sodium Value Chain Analysis
- 12.1.1 Montelukast Sodium Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Montelukast Sodium Production Mode & Process
- 12.2 Montelukast Sodium Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Montelukast Sodium Distributors
- 12.2.3 Montelukast Sodium Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst